Semaglutide is a injectable medication used to treat type 2 diabetes. It belongs to a class of medications called GLP-1 receptor agonists, which work by stimulating the release of insulin in response to high blood sugar levels, and by reducing the production of glucose by the liver.
Semaglutide shots in Jacksonville are administered once a week via subcutaneous injection, and has been shown to improve blood sugar control, reduce the risk of cardiovascular events, and promote weight loss. It has also been approved for the treatment of obesity in individuals with a body mass index (BMI) of 30 or higher.
Like all medications, it is important to discuss the potential benefits and risks of Semaglutide with your healthcare provider before starting treatment.
More reading: Wilding, John PH, et al. “Once-weekly semaglutide in adults with overweight or obesity.” New England Journal of Medicine (2021).